About Dr. Li Zhixin
Dr. Li Zhixin (李志新) is Chief Physician, Professor, and Director of Thoracic Surgery at Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine — China's premier thoracic specialty hospital and the national leader in lung cancer surgery. He is one of China's foremost thoracic surgeons, with particular expertise in minimally invasive thoracoscopic (VATS) and robotic-assisted surgery for early and locally advanced lung cancer, complex pulmonary resections, and mediastinal tumor surgery.
Dr. Li has performed thousands of thoracoscopic lung resections and is a national leader in the adoption and refinement of uniportal VATS — a single-incision minimally invasive approach that minimizes surgical trauma, reduces post-operative pain, and accelerates recovery compared to conventional multi-port or open thoracotomy. His surgical program at Shanghai Chest Hospital manages one of the highest volumes of lung cancer operations in China, with a case mix that includes complex segmentectomies, sleeve resections, and extended resections for locally advanced disease that require the highest level of thoracic surgical expertise.
Hospital Affiliation
Shanghai Chest Hospital is China's most specialized and highest-volume thoracic disease center, dedicated exclusively to diseases of the chest. The Department of Thoracic Surgery at Shanghai Chest Hospital performs more lung cancer operations than any other center in China, with a multidisciplinary team that integrates thoracic surgery, medical oncology, radiation oncology, interventional pulmonology, and pathology. The surgical suite is equipped with the latest generation robotic surgical systems (da Vinci Xi), advanced thoracoscopic platforms, and intraoperative navigation technology for precise anatomical resection.
Clinical Expertise
- Minimally invasive lung cancer surgery — uniportal VATS lobectomy; multi-port VATS lobectomy; robotic-assisted lobectomy; VATS segmentectomy for small nodules and ground-glass opacities (GGO); sublobar resection for early-stage NSCLC
- Complex pulmonary resections — sleeve lobectomy (bronchoplasty); pneumonectomy; extended resection with chest wall, diaphragm, or pericardial involvement; completion pneumonectomy
- Mediastinal tumor surgery — thymoma and thymic carcinoma resection; mediastinal germ cell tumors; neurogenic tumors; minimally invasive thymectomy for myasthenia gravis
- Esophageal surgery — minimally invasive esophagectomy (MIE) for esophageal cancer; Ivor Lewis and McKeown approaches; esophageal reconstruction
- Pleural disease surgery — VATS pleurodesis; decortication for empyema; pleural mesothelioma surgery; pleurectomy/decortication (P/D)
- Pulmonary nodule management — CT-guided localization and resection of small pulmonary nodules; intraoperative navigation; management of multiple synchronous nodules
- Post-neoadjuvant surgery — resection following neoadjuvant chemotherapy or chemo-immunotherapy for locally advanced NSCLC
Academic & Research Contributions
Dr. Li Zhixin has authored and co-authored numerous peer-reviewed publications in leading thoracic surgery and oncology journals, with a research focus on minimally invasive surgical techniques, oncological outcomes of VATS versus open resection, and the surgical management of ground-glass opacity nodules. He has presented his work at major international thoracic surgery conferences including ESTS, AATS, and STS, and contributes to the development of national clinical guidelines for lung cancer surgical management in China.
He is a recognized expert in uniportal VATS technique and has conducted surgical training and live demonstration programs for thoracic surgeons across China and internationally, contributing to the dissemination of minimally invasive thoracic surgery expertise.
Why International Patients Choose Dr. Li Zhixin
For international patients with early-stage lung cancer or pulmonary nodules requiring surgical resection, Shanghai Chest Hospital under Dr. Li's leadership offers a combination of surgical volume, technical expertise, and minimally invasive capability that is genuinely among the best in the world. The hospital's case volume — the highest in China for lung cancer surgery — means that complex cases including sleeve resections, multi-nodule resections, and post-neoadjuvant surgery are managed routinely by a team with unmatched experience.
Surgical costs at Shanghai Chest Hospital are substantially lower than equivalent thoracic surgery in Western healthcare systems, with no compromise in surgical expertise, equipment quality, anesthesia standards, or post-operative care. For patients with early-stage NSCLC detected on screening CT, prompt access to Dr. Li's surgical program through CMCS can facilitate timely curative resection without the waiting times that may be encountered in public healthcare systems abroad.
What to Expect at Your Consultation
Consultations with Dr. Li begin with a comprehensive thoracic surgical assessment including review of CT chest (with thin-slice reconstruction), PET-CT if available, pulmonary function tests, bronchoscopy reports, and pathology if biopsy has been performed. CMCS will arrange certified translation of all prior medical records and imaging in advance. Dr. Li will outline the surgical approach, extent of resection, expected oncological outcomes, procedural risks, and recovery timeline. Most patients undergoing VATS lobectomy are discharged within 3–5 days. A written English-language consultation summary is provided after every appointment.
Book a Consultation Through CMCS
China Medical Concierge Shanghai (CMCS) provides end-to-end support for international patients seeking thoracic surgery with Dr. Li Zhixin at Shanghai Chest Hospital, including priority consultation and surgical scheduling, certified medical translation, pre-operative imaging review, surgical logistics, and post-operative follow-up coordination. Contact us at contact@medicalsh.com, WeChat: gezhanglao, or visit medicalsh.com.
0 commentaire